Tag

21 results found for: COPD

Inhaled corticosteroids linked to COPD fractures

Long-term use of high dose inhaled corticosteroids is associated with a “modest” increased risk of fractures in COPD patients

Cardiovascular risk rises with COPD treatments

A large increase in CVD incidence takes place within 30 days of starting certain COPD therapies, research finds

Winter ailments: Help cut the queues

Winter provides the perfect opportunity for pharmacy to ease the pressure on GP surgeries and A&E departments

What’s new in COPD & asthma care (part 2)

Here we consider the role community pharmacy teams can play in the therapeutic management of COPD

What’s new in COPD & asthma care (part 1)

What symptoms should pharmacists look for with COPD and when should suspected cases be referred to a GP?

Inhaled steroids in COPD increase oral thrush risk

Inhaled corticosteroids for COPD appear to double the risk of developing oral thrush compared to long-acting bronchodilators

NHS invests in apps to manage chronic conditions

Investment is being channelled into the technological advancement of the NHS and, in particular, apps for the management of chronic conditions

Supporting World COPD Day

Pharmacy teams are being encouraged to support World COPD Day 2016 on Wednesday 16 November

Supporting patients with COPD

This CPD module looks at how community pharmacists can support patients with chronic obstructive pulmonary disease

Update: COPD treatment adherence falls “precipitously” early on

Adherence to maintenance treatments for COPD falls sharply in the first six months of treatment, researchers find

Update: COPD exacerbations speed lung function loss

Even mild COPD exacerbations accelerate loss of lung function, researchers find

COPD link to anxiety highlighted

Patients with chronic obstructive pulmonary disease can experience generalised anxiety disorder

UKCPA viewpoint: Using generic inhalers

We consider the role of generic inhalers in asthma and COPD.

New COPD inhalers

Two new inhaler devices have been launched for the treatment of COPD

COPD increases sudden cardiac death risk

COPD is associated with a 30 per cent increased risk of sudden cardiac death

'Significant improvements' in COPD

Community pharmacies can make significant improvements to the lives of COPD patients, a recent study shows.

COPD increases risk of Parkinsons

Chronic obstructive pulmonary disease (COPD) seems to increase the risk of developing Parkinson’s disease  

COPD patient's greater heart failure risk

Patients with COPD are at increased risk of heart failure

COPD linked to mild cognitive impairment

COPD increases the risk of non-amnesic mild cognitive impairment

Pharmacy services could save NHS £470m

Commissioning pharmacy services could save the NHS over £470m a year.
Previous 1 2 Next

Latest

Latest pharmacy contractor data

Community pharmacy numbers in England declined by 82 in the past year, according to figures released by NHS Digital

FIP fun run to raise money for Pharmacist Support

Charity Pharmacist Support is partnering with the International Pharmacy Federation (FIP) for its annual congress fun ru...

Views

Where should accountability lie?

By David Gallier-Harris, a member of the DHSC’s rebalancing board, writing in a personal capacity The superintend...

Popular

NHS to roll out patient app

A new NHS app, which will be available free to patients in England from December 2018, will make it quicker and easier t...

Next steps for social care

Four more areas are joining the ten areas that are already part of the integrated care development programme. The NHS sa...

PPIs may increase pneumonia risk

Research suggests an increase in pneumonia associated with ongoing PPI treatment



This website is for healthcare professionals only. By clicking "Accept" to hide this message or by clicking into any content on this website, you confirm you are a healthcare professional, consent to accepting cookies in accordance with our Cookie Policy and agree to Pharmacy Magazine’s Terms of Use and Privacy Policy.